Real‐time quantitation of bcr‐abl transcripts in haematological malignancies

R Saffroy, A Lemoine, P Brezillon… - European journal of …, 2000 - Wiley Online Library
We have applied an automated real‐time quantitative PCR assay using a double‐labeled
fluorogenic probe to detect t (9; 22)‐positive cells in haematological malignancies. The …

Adoptive allogeneic immunotherapy–history and future perspectives

M Schleuning - Transfusion science, 2000 - Elsevier
For more than 30 yrs allogeneic hematopoietic stem cell transplantations have been
successfully performed in patients with hematologic malignancies and bone marrow aplasia …

Studies of minimal residual disease in acute lymphocytic leukemia

W Stock, Z Estrov - Hematology/oncology clinics of North America, 2000 - Elsevier
During the past 2 decades, there has been considerable progress in the treatment of both
childhood and adult acute lymphocytic leukemia (ALL). Currently, 70% to 90% of adults …

Minimal residual disease in chronic myeloid leukaemia patients

A Hochhaus - Best Practice & Research Clinical Haematology, 2002 - Elsevier
In many ways, chronic myeloid leukaemia (CML) serves as a paradigm for the utility of
molecular methods in the diagnosis of malignancy or for monitoring the response of the …

Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples

W Stock, D Yu, T Karrison, D Sher… - International …, 2006 - spandidos-publications.com
Molecular monitoring of the BCR-ABL transcript in chronic myelogenous leukemia (CML)
using quantitative RT-PCR provides clinicians with important diagnostic and prognostic …

Quantitative intra-individual monitoring of BCR-ABL transcript levels in archival bone marrow trephines of patients with chronic myeloid leukemia

O Bock, U Lehmann, H Kreipe - The Journal of molecular diagnostics, 2003 - Elsevier
We established a quantitative real-time RT-PCR assay for the detection of chimeric BCR-
ABL transcripts in archival formalin-fixed bone marrow trephines, both acrylate-embedded …

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity …

T Lange, M Deininger, R Brand, U Hegenbart, H Al-Ali… - Leukemia, 2004 - nature.com
Kinetics of BCR-ABL transcript elimination and its prognostic implications on relapse were
analyzed in patients with chronic myeloid leukemia (CML) after reduced intensity …

[图书][B] Chronic Myeloid Leukemia: Biology and Treatment

AM Carella, GQ Daley, CJ Eaves, JM Goldman… - 2001 - taylorfrancis.com
In this volume, an international team of experts in chronic myeloid leukemia share their
expertise. In particular, they contribute their insights on the latest advances in understanding …

Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes

S Saussele, A Weisser, MC Müller, M Emig, PL Rosée… - Leukemia, 2000 - nature.com
Recently, a polymorphic base in exon 13 of the BCR gene (exon b2 of the major breakpoint
cluster region) has been identified in the eighth position before the junctional region of BCR …

[HTML][HTML] Avaliação laboratorial da doença residual mínima na leucemia mielóide crônica por Real-Time PCR

AC Grando, SC Wagner - Jornal Brasileiro de Patologia e Medicina …, 2008 - SciELO Brasil
A leucemia mielóide crônica (LMC) representa 15% das leucemias e apresenta três fases:
crônica, acelerada e crise blástica. A partir da análise citogenética, pode ser identificado o …